Genomic characterisation of Staphylococcus aureus ST121 isolated from hospitalised patients in South Africa
To the Editor: Staphylococcus aureus is a ubiquitous Gram-positive bacterium recognised as a major cause of minor to life-threatening infections in hospital and community settings. [1] Its pathogenesis is associated with the expression of a variety of structural and secreted virulence factors that enable host colonisation, invasion of tissue and dissemination. Life-threatening staphylococcal infections are generally caused by the co-presence and combined actions of staphylococcal enterotoxins (sea-sej), toxic shock syndrome toxin-1 (tst-1), exfoliative toxins (eta and etb) and the pantonvalentine leucocidin. [2] S. aureus is usually categorised as methicillinsusceptible S. aureus (MSSA) or methicillin-resistant S. aureus (MRSA) according to its susceptibility to beta-lactams. [3] Although there is considerable controversy regarding the virulence of MSSA and MRSA isolates, it has been agreed that both have enormous virulence and pathogenicity capacities. [4] The isolates described in this letter formed part of a bigger study investigating the molecular epidemiology of antibiotic resistance in clinical and carriage samples from patients admitted to public hospitals in uMgungundlovu District, KwaZulu-Natal Province, South Africa (SA). The isolates were identified using biochemical tests and antimicrobial susceptibility testing was performed by broth microdilution. The European Committee on Antimicrobial Susceptibility testing (EUCAST) breakpoints [5] were used for interpretation of the results and S. aureus ATCC 29213 was used as the control. Whole-genome sequencing (WGS) analysis was performed on an Illumina MiSeq platform (Illumina Inc., USA) with 100 × coverage. CLC Genomics Workbench version 10 (CLC Bio, QIAGEN, Denmark) and SPAdes [6] were used for de novo assembly. The bacterial analysis pipeline of GoSeqIt (Denmark) tools was used to annotate and identify known acquired antibiotic-resistant genes via ResFinder, [7] virulence factors using VirulenceFinder [8] and mobile genetic elements through PlasmidFinder. [9] Genomic DNA was extracted using the GenElute bacterial genomic DNA kit (SigmaAldrich, USA) according to the manufacturer's instructions. The multi-locus sequence type was determined from WGS data.
The two MSSAs, G703N1B1 (accession no. PGXA00000000) and G703N2B1 (accession no. PGWZ00000000) originated from nasal samples collected at admission and after 48 hours from a patient admitted to a tertiary hospital. Both isolates were ascribed to the sequence type 121 and exhibited multidrug resistance (Table 1) . WGS confirmed this resistance profile by identifying several resistance genes in both isolates along with 18 virulence genes ( Table 1) .
To the best of our knowledge, this is the first report of communityacquired methicillin-susceptible S. aureus (CA-MSSA) ST121 isolated from a nasal carriage sample in SA. Rao et al. [10] demonstrated that the genetic lineage ST121 is an emerging and hypervirulent clone. Although we did not quantify the levels of production and mobilisation of the virulence determinants, the detection of 18 virulence genes in the CA-MSSA ST121 confirmed that this genetic lineage could probably contribute to severe outbreak situations, not only in communities but also in hospitals if infection control measures are not sufficiently implemented. This necessitates improvements in routine screening and reinforcement of infection, prevention and control measures. 
